US FDA reports new steps in drug safety

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2007年 / 1138卷 / 1期

关键词：

Veteran Affair; Medical Device; Medical Product; Comprehensive Approach; Strong Interagency;

D O I：

10.2165/00128415-200711380-00005

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：3 / 3

相关论文

共 50 条

[1] The US FDA requires a “new vision of drug safety”
Reactions Weekly, 2006, 1126 (1) : 3 - 3
[2] US FDA to create new Drug Safety Oversight Board
Reactions Weekly, 2005, 1039 (1) : 3 - 3
[3] Update on the Office of Drug Safety at the US FDA
Reactions Weekly, 2004, 1015 (1) : 3 - 4
[4] Reports Isavuconazole Granted Orphan Drug Designation by US FDA
不详
CLINICAL INFECTIOUS DISEASES, 2013, 57 (04) : II - II
[5] Report on Drug Safety and the US FDA by the Institute of Medicine
Anthony W. Fox
International Journal of Pharmaceutical Medicine, 2006, 20 (5) : 289 - 291
[6] US FDA enhancing postmarketing drug safety surveillance
Reactions Weekly, 2019, 1780 (1) : 3 - 3
[7] US FDA 2009 drug safety warnings analysed
Reactions Weekly, 2012, 1388 (1) : 4 - 4
[8] US FDA Enhancing Postmarketing Drug Safety Surveillance
不详
PHARMACEUTICAL MEDICINE, 2020, 34 (01) : 64 - 64
[9] DRUG PROMOTION - FDA STEPS IN
BUDIANSKY, S
NATURE, 1982, 298 (5877) : 784 - 785
[10] US FDA report highlights ongoing drug safety initiatives
Reactions Weekly, 2018, 1700 (1) : 2 - 2

← 1 2 3 4 5 →